Status:
UNKNOWN
cliNIcal sCEnarios and Pathophysiology of Atrial Fibrillation
Lead Sponsor:
Policlinico Casilino ASL RMB
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation (AF) remains the most common sustained cardiac arrhythmia with prevalence and incidence continuously increasing worldwide. Current guidelines propose an etiological, symptom-based ...
Eligibility Criteria
Inclusion
- Patients with electrocardiographic diagnosis of Atrial Fibrillation (New Onset, Paroxysmal, Persistent, Long Standing Persistent and Permanent) admitted to the Emergency Room and/or Cardiology Department /ambulatory care center of our Hospital
- Age \>18 years old
- Patients who can give their written informed consent.
Exclusion
- Age \<18 years old
- Patients who cannot give their written informed consent.
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04320134
Start Date
April 15 2020
End Date
April 15 2025
Last Update
March 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.